U.S. Flow Cytometry Market Transforms with Smaller, More Robust, Point-of-care Systems...

U.S. Flow Cytometry Market Transforms with Smaller, More Robust, Point-of-care Systems and Software Applications

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c88296) has announced the
addition of "U.S. Flow Cytometry Markets" to their offering.

This Frost & Sullivan research service titled U.S. Flow Cytometry
Markets provides revenue forecasts for the overall market, with
detailed market and technology trends. Moreover, the research service
provides an in-depth analysis of market-wide and segment-specific
drivers, restraints, and challenges, with the corresponding strategic
recommendations. In this research, Frost & Sullivan's expert analysts
thoroughly examine the following flow cytometry markets: research and
clinical.

High-throughput, miniature, and more robust flow cytometry
instruments with multiple applications to meet the needs of both
research and clinical sectors are the order of the day. This will
attract more non-users into the end-user fold and drive the short-term
growth of the market. For long-term growth, market participants will
have to develop next-generation, integrated, point-of-care, and
miniature systems. Companies can benefit greatly by focusing on
integrating complementary technologies such as imaging and
multiplexing and developing microfluidics-based miniature systems,
says the analyst of this research. They should also invest heavily in
developing automated systems with improved workflow in terms of sample
processing and analysis, and the ability to establish rapid exchange
of data across the systems. Once these technologies are ready for
commercial launches, they are expected to revolutionize the market.

Despite the availability of such advanced cytometers, end users
still perceive them as complicated, expensive, and high on maintenance
and operational costs. This lack of end-user awareness of the smaller
and better systems has greatly hampered the wide adoption of
cytometers. Therefore, participants should disseminate information
about the utility and cost effectiveness of their products through
webcasts and electronic newsletters. These methods will help them
demonstrate the advantages of the software and technical capabilities
of their instruments even in non-traditional applications such as cell
biology and protein analysis. Developing new and affordable
instruments will also help market entrants establish their credibility
among the lower tiers of end users. They can also offer physical
demonstrations at various conferences, trade shows, and laboratories
to drive home their marketing message.

Various Schemes to Contain Costs to Greatly Aid the Uptake of
Cytometers

Flow cytometers' heavy price tags and additional expenses of
service contracts for the maintenance of instruments discourage many
researchers with limited funding from adopting them. To compound this
situation, end users' purchasing power has further diminished with the
recent decline in funding opportunities. Manufacturers can overcome
this limitation by implementing financing schemes, which will allow
researchers to pay for the instrument in installments over the course
of use, notes the analyst. This strategy will help manufacturers
capture the untapped market and make the technology more affordable.

Maintenance funding is another crucial aspect that needs to be
addressed by market participants, since flow cytometers, being complex
systems, will require technical support and services for the entire
duration of their lifetime. Market participants can take advantage of
this scenario by distinguishing themselves through quality and
cost-effective repair and support services. Manufacturers should
develop multiple, customized, and cost-effective service programs
without compromising quality assurances such as full onsite service
contracts, laser-only service coverage, preventive maintenance, and
equipment validation to satisfy all types of end users, remarks the
analyst. These services and support will help meet researchers' needs
for superior efficiency and coverage, despite budgetary constraints.

Technologies

The following technologies are covered in this research:

- High end instruments (8 to 16 colors)

- Mid-end instruments (4 to 7 colors)

- Low-end instruments (less than 4 colors)

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following
market sectors in this research:

By Markets

- Research flow cytometry

- Clinical flow cytometry

By Applications

- Research applications: cell cycle analysis, apoptosis, cellular
and molecular profiles, acellular molecular detection, cell
proliferation, transfection and cell viability

- Clinical applications: Diagnosis of hematological malignancies,
detection of minimal residual disease (MRD), lymphocyte enumeration
for immunodeficiency disease, analysis of DNA ploidy, the cell cycle
and cell death, measurement of the efficacy of cancer chemotherapy,
reticulocyte enumeration, cell function analysis, organ
transplantation and hematopoietic cell therapy

By End Users

- Academic institutions

- Hospitals

- Clinical testing laboratories and medical schools

- Government agencies

- Other non-profit laboratories

- Commercial customers such as pharmaceutical companies,
biotechnology companies, diagnostic companies.

For more information visit
http://www.researchandmarkets.com/reports/c88296.

Research and Markets
Laura Wood
Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com

Copyright Business Wire 2008